Penumbra (PEN) Interest & Investment Income (2023 - 2026)
Penumbra's (PEN) quarterly Interest & Investment Income came in at $3.5 million in Q1 2026, down 1.54% year-on-year from $3.5 million in Q1 2025, and down 0.95% on a QoQ basis from $3.5 million in Q3 2025.
Penumbra (PEN) Interest & Investment Income (2023 - 2026) Analysis & Trends
Penumbra (PEN) has 4 years of Interest & Investment Income data on file, last reported at $3.5 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Penumbra | 12.55 Bn | 11.94 Bn | 253.41 Mn | 3.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.45 Mn |
| Sep 30, 2025 | 3.49 Mn |
| Jun 30, 2025 | 4.48 Mn |
| Mar 31, 2025 | 3.51 Mn |
| Sep 30, 2024 | 4.41 Mn |
| Jun 30, 2024 | 3.09 Mn |
| Mar 31, 2024 | 2.53 Mn |
| Sep 30, 2023 | 679,000.00 |
| Jun 30, 2023 | 1.65 Mn |
| Mar 31, 2023 | 644,000.00 |